Document is current
Any future updates will be listed below
-
Authors
Liang, Xiuming https://orcid.org/0000-0003-0202-1211
Gupta, Dhanu https://orcid.org/0000-0003-0163-2678
Xie, Junhua
Van Wonterghem, Elien
Van Hoecke, Lien
Hean, Justin
Niu, Zheyu
Ghaeidamini, Marziyeh
Wiklander, Oscar P. B. https://orcid.org/0000-0003-1176-8114
Zheng, Wenyi https://orcid.org/0000-0003-2416-5822
Wiklander, Rim Jawad
He, Rui
Mamand, Doste R.
Bost, Jeremy https://orcid.org/0000-0002-3804-0521
Zhou, Guannan
Zhou, Houze
Roudi, Samantha https://orcid.org/0000-0003-3923-3410
Estupiñán, H. Yesid https://orcid.org/0000-0002-9388-5957
Rädler, Julia https://orcid.org/0000-0002-4839-3822
Zickler, Antje M. https://orcid.org/0000-0001-5001-6586
Görgens, André https://orcid.org/0000-0001-9198-0857
Hou, Vicky W. Q.
Slovak, Radka https://orcid.org/0000-0002-9963-5975
Hagey, Daniel W. https://orcid.org/0000-0001-9246-6235
de Jong, Olivier G. https://orcid.org/0000-0002-5952-9617
Uy, Aileen Geobee
Zong, Yuanyuan
Mäger, Imre https://orcid.org/0000-0003-2242-7227
Perez, Carla Martin
Roberts, Thomas C. https://orcid.org/0000-0002-3313-7631
Carter, Dave
Vader, Pieter https://orcid.org/0000-0002-7059-8920
Esbjörner, Elin K. https://orcid.org/0000-0002-1253-6342
de Fougerolles, Antonin
Wood, Matthew J. A.
Vandenbroucke, Roosmarijn E. https://orcid.org/0000-0002-8327-620X
Nordin, Joel Z. https://orcid.org/0000-0002-3653-7710
EL Andaloussi, Samir https://orcid.org/0000-0003-4468-9113
- License Information
-
More Information
Article History
Received: 12 June 2024
Accepted: 17 April 2025
First Online: 29 April 2025
Competing interests
: O.W., J.Z. N., D.G. A.G., M.J.A.W. and S.E.-A. are consultants and stakeholders in Evox Therapeutics Limited, Oxford, United Kingdom. A.D.F., and J.H. are employees of Evox Therapeutics Limited, Oxford, United Kingdom. Evox Therapeutics filed a patent application related to the data used in this work. The patent was applied by Evox Therapeutics Limited. The inventors are Xiuming Liang, Dhanu Gupta, Samir EL Andaloussi and Joel Nordin. Its application number is PCT/EP22/84310 which is still under evaluation. The development of VEDIC and VFIC systems of this work was included in this patent. All the data are available in the manuscript or in the supplemental information. Materials are available upon signing the material transfer agreement (MTA) submitted to S.E.-A. and Evox Therapeutics Limited, Oxford, United Kingdom. The remaining authors declare no competing interests.
